Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kura Oncology (NQ: KURA )

9.000 -0.120 (-1.32%)
Streaming Delayed Price Updated: 10:40 AM EDT, Oct 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 159,360
Open 9.200
Bid (Size) 8.980 (3)
Ask (Size) 9.010 (2)
Prev. Close 9.120
Today's Range 8.960 - 9.390
52wk Range 8.340 - 17.27
Shares Outstanding 68,438,576
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Allarity Therapeutics Gaining Momentum? Hits Multiple Milestones Including Positive Publications In PLOS One And At ASCO, Positive Early Data From An Ongoing Clinical Trial, And External Partnering For Its DRP® Technology
Allarity Therapeutics (NASDAQ: ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therapies coupled with companion diagnostics. 
Via Benzinga
Analyst Expectations for Kura Oncology's Future
Via Benzinga

Performance

YTD
-25.31%
-25.31%
1 Month
-10.54%
-10.54%
3 Month
-15.09%
-15.09%
6 Month
-29.58%
-29.58%
1 Year
-31.14%
-31.14%

More News

Read More
Sushi, Bans, And Business: Japan's Radioactive Water Release Sparks Concerns For US Seafood Traders
Via Benzinga
The Latest Analyst Ratings for Kura Oncology
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Via Benzinga
Where Kura Oncology Stands With Analysts
Via Benzinga
Analyst Ratings for Kura Oncology
Via Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
Via Benzinga
7 Best Cancer Stocks to Invest in Now
Via MarketBeat
Topics Death
Exposures Death
Over $27M Bet On Zymeworks? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Kura Oncology: Q1 Earnings Insights
Via Benzinga
Kura Oncology's Earnings Outlook
Via Benzinga
Kura Oncology Shares Fall After Updated Ziftomenib Data At ASH Meeting
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Via Benzinga
MicroVision, RadNet And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2023
Via Benzinga
3 Under-the-Radar Stocks That AI Predicts Will Soar in May
Via InvestorPlace
First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
7 Undiscovered Stocks to Watch for the Next Big Thing
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Kura Oncology Stock Is Moving Higher Tuesday Morning
Via Benzinga
Cramer Is Holding This Biotech Stock
Via Benzinga
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.